Issue Trust is a precondition, not a soft variable, because the arrangements have no precedent

Summary

In its closing reflections, the report names trust as one of two tensions that will shape whether these ten technologies arrive well. Several of them ask the public, regulators and clinicians to accept arrangements without precedent. A therapy made for one person cannot be judged with trial designs built around identical doses in large populations, and the frameworks for proving its safety are still being written. A protein from an engineered microbe asks consumers to trust a process they cannot see, in a category that lacks settled language. A grid balanced by millions of distributed assets asks households and fleet operators to share data and cede some control over charging. The report therefore treats trust not as a soft factor but as a precondition that has to be built on purpose.